Nasodine COVID-19 Trial Concludes Recruitment – Results in June 2023

  03 Apr 2023

Firebrick Pharma is pleased to announce that its Phase 2 COVID-19 trial of Nasodine® Nasal Spray has closed for recruitment.

Read More